Cannabis Bioscience International Holdings Inc.
Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for … Read more
Cannabis Bioscience International Holdings Inc. (CBIH) - Total Assets
Latest total assets as of August 2025: $18.94K USD
Based on the latest financial reports, Cannabis Bioscience International Holdings Inc. (CBIH) holds total assets worth $18.94K USD as of August 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cannabis Bioscience International Holdings Inc. - Total Assets Trend (2007–2025)
This chart illustrates how Cannabis Bioscience International Holdings Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cannabis Bioscience International Holdings Inc. - Asset Composition Analysis
Current Asset Composition (May 2025)
Cannabis Bioscience International Holdings Inc.'s total assets of $18.94K consist of 91.2% current assets and 8.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 40.6% |
| Accounts Receivable | $15.54K | 48.7% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2025)
This chart illustrates how Cannabis Bioscience International Holdings Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cannabis Bioscience International Holdings Inc.'s current assets represent 91.2% of total assets in 2025, a decrease from 100.0% in 2007.
- Cash Position: Cash and equivalents constituted 40.6% of total assets in 2025, down from 70.7% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 48.7% of total assets.
Cannabis Bioscience International Holdings Inc. Competitors by Total Assets
Key competitors of Cannabis Bioscience International Holdings Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Cannabis Bioscience International Holdings Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Cannabis Bioscience International Holdings Inc. generates 9.51x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Cannabis Bioscience International Holdings Inc. is currently not profitable relative to its asset base.
Cannabis Bioscience International Holdings Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.02 | 0.02 | 0.35 |
| Quick Ratio | 0.02 | 0.02 | 0.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-996.73K | $ -833.35K | $ -174.36K |
Cannabis Bioscience International Holdings Inc. - Advanced Valuation Insights
This section examines the relationship between Cannabis Bioscience International Holdings Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.01 |
| Latest Market Cap to Assets Ratio | 121.39 |
| Asset Growth Rate (YoY) | -44.2% |
| Total Assets | $31.88K |
| Market Capitalization | $3.87 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Cannabis Bioscience International Holdings Inc.'s assets at a significant premium ( 121.39x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Cannabis Bioscience International Holdings Inc.'s assets decreased by 44.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Cannabis Bioscience International Holdings Inc. (2007–2025)
The table below shows the annual total assets of Cannabis Bioscience International Holdings Inc. from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-05-31 | $31.88K | -44.23% |
| 2024-05-31 | $57.16K | +31.76% |
| 2023-05-31 | $43.38K | -60.52% |
| 2022-05-31 | $109.89K | -26.14% |
| 2021-05-31 | $148.79K | +16.56% |
| 2020-05-31 | $127.65K | -99.86% |
| 2011-05-31 | $91.00 Million | +26.90% |
| 2010-05-31 | $71.71 Million | +105.83% |
| 2009-05-31 | $34.84 Million | +85881.90% |
| 2008-05-31 | $40.52K | +41.14% |
| 2007-05-31 | $28.71K | -- |